In this episode, we meet Lauren Li, Global Head of Digital Health at Ipsen. Ipsen is a global biopharmaceutical group focused on innovation and Specialty Care in three key therapeutic areas — Oncology, Neuroscience and Rare Diseases. As Global Head of Digital Health, Lauren leads a team to deliver “beyond the drug” solutions for patients, caregivers, physicians, and payors through human-centered design, cross-functional collaboration, and value-based partnerships.

Prior to Ipsen, Lauren drove Digital Innovation at Amgen, led Strategy & Operations at Princess Margaret Cancer Centre, co-founded a successful family business, and was a consultant at McKinsey & Company in the Toronto office. Lauren holds an MBA from Harvard Business School and a B.A. in Economics from Princeton University.

Lauren shares her perspectives on what makes a successful digital health-biopharma partnership, how digital health solutions can effectively demonstrate value to payors, employers, and pharma, and the challenges that remain for digital health adoption. Lauren also shares her reflections and guidance to early career professionals and MBAs interested in pursuing a career in the intersection of digital innovation and biopharma.

Lauren Li, Ipsen, on Beyond the Drug innovation